Loading…
Twist Bioscience Corporation is projected to rise to $107.62 by 2027, a +68% move from its current price of $64.17. TWST is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $61.73 | $64.18 | $66.72 | +0.01% |
| May 30 | $60.75 | $64.19 | $67.81 | +0.02% |
| May 31 | $60.01 | $64.19 | $68.67 | +0.04% |
| Jun 1 | $59.40 | $64.20 | $69.39 | +0.05% |
| Jun 2 | $58.86 | $64.21 | $70.04 | +0.06% |
| Jun 3 | $58.38 | $64.22 | $70.64 | +0.07% |
| Jun 4 | $57.94 | $64.22 | $71.18 | +0.08% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $57.94 | $64.22 | $71.18 | +0.08% |
| Week 2 | $55.57 | $64.28 | $74.35 | +0.17% |
| Week 3 | $53.83 | $64.33 | $76.88 | +0.25% |
| Week 4 | $52.41 | $64.38 | $79.10 | +0.33% |
| Week 5 | $51.19 | $64.44 | $81.11 | +0.42% |
| Week 6 | $50.12 | $64.49 | $82.98 | +0.50% |
| Week 7 | $49.16 | $64.54 | $84.74 | +0.58% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. It offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs.
The company provides oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also offers NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses.
Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
Twist Bioscience Corporation (TWST) is a healthcare-focused biotechnology company known for manufacturing synthetic DNA-based products. It operates in a specialized sector of genetic research tools and platforms with applications across therapeutics, diagnostics, data storage, and academic research. The stock sits in the public markets with a current price of $64.87 and a market cap of $4.04B, ranking 1522 by market capitalization.
The price outlook is notably bullish over the long run, as reflected in the year-by-year forecast. The model projects a path of rising averages from $64.87 in 2026 to $194.29 by 2030, and extending to $1,286.00 by 2050, signaling substantial upside over the coming years. ROI projections accompany this path, reaching 199.5% by 2030 and 1882.4% by 2050, though near-term movement can vary and outcomes are not guaranteed.
A major floor 36.0% below — a decisive break under it would weaken the trend.
The nearest floor, 23.4% below — buyers have tended to step in here.
Price is pressing into resistance (1.1% away) — a breakout level to watch.
A major ceiling 17.0% above — clearing it would confirm fresh momentum.
Key TWST support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TWST market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $60.42 | Buy | $60.86 | Buy |
| MA 10 | $55.79 | Buy | $58.41 | Buy |
| MA 20 | $56.67 | Buy | $57.07 | Buy |
| MA 50 | $53.86 | Buy | $54.21 | Buy |
| MA 100 | $49.26 | Buy | $49.56 | Buy |
| MA 200 | $39.47 | Buy | $44.37 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 64.10 | Neutral |
| Stoch RSI (14) | 94.49 | Sell |
| CCI (20) | 155.09 | Buy |
| Williams %R (14) | -4.46 | Info |
| MACD (12,26,9) | 0.90 | Buy |
| ROC (12) | 12.88 | Buy |
| Bollinger %B (20,2) | 0.94 | Neutral |
| Stochastic %K (14) | 95.54 | Sell |
| TRIX (15) | 0.12 | Buy |
| Awesome (5,34) | 3.38 | Buy |
| Ultimate (7,14,28) | 78.67 | Sell |
| Momentum (10) | 8.22 | Buy |
| Aroon Osc (25) | 24.00 | Buy |
| Hull MA (9) | 65.77 | Sell |
| ADX (14) | 17.09 | Neutral |
| ATR (14) | 2.11 | Info |
The 30-day technical picture is negative? No, it is described as BULLISH with RSI14 at 70. The stock is trading above key moving averages, with SMA50 at $53.47 and SMA200 at $39.28, suggesting upside potential.
Support is positioned at $49.17 and resistance at $64.87, with a 30-day price range of $49.82 to $84.47. The bullish sentiment is reinforced by the current technical setup and momentum indicators, reflecting constructive near-term dynamics for TWST.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $32.39 | $64.17 | $98.48 | 0% | Neutral | |
| $81.84 | $107.62 | $151.78 | +68% | Bullish | |
| $102.35 | $140.16 | $207.36 | +118% | Bullish | |
| $111.68 | $158.29 | $243.13 | +147% | Bullish | |
| $131.52 | $192.26 | $304.73 | +200% | Bullish | |
| $127.86 | $192.32 | $313.27 | +200% | Bullish | |
| $130.87 | $202.20 | $337.50 | +215% | Bullish | |
| $180.54 | $286.13 | $488.25 | +346% | Bullish | |
| $211.40 | $343.34 | $597.82 | +435% | Bullish | |
| $232.75 | $387.05 | $686.64 | +503% | Bullish | |
| $321.92 | $597.66 | $1,145.95 | +831% | Bullish | |
| $578.26 | $1,285.03 | $2,753.99 | +19.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $32.39 | $64.17 | $76.05 | +0.00% |
| June 2026 | $56.05 | $66.43 | $81.07 | +3.53% |
| July 2026 | $54.07 | $64.87 | $80.66 | -2.35% |
| August 2026 | $53.36 | $64.63 | $81.53 | -0.37% |
| September 2026 | $56.95 | $69.53 | $88.74 | +7.59% |
| October 2026 | $59.32 | $72.95 | $94.09 | +4.91% |
| November 2026 | $58.49 | $72.40 | $94.24 | -0.76% |
| December 2026 | $60.23 | $75.00 | $98.48 | +3.60% |
Click any year to see its month-by-month TWST forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, TWST is projected to trade between $32.39 and $98.48, averaging $64.17 — a potential gain of 0% from today's $64.17. A consolidation phase looks the most probable path here.
Twist Bioscience Corporation's 2027 outlook centres on $107.62, within a $81.84 to $151.78 range. That is up +68% on the projected 2026 average. That marks a +68% change versus current levels. Momentum favours further upside here.
By 2028, TWST could reach as high as $207.36, with a base case around $140.16 and support toward $102.35 — roughly +118% from $64.17. Buyers look set to stay in control over this stretch.
Expect TWST to range from $111.68 to $243.13 through 2029. The $158.29 average target implies a +147% move from current prices. That is up +13% on the projected 2028 average. Momentum favours further upside here.
The TWST price prediction for 2030 points to an average of $192.26 (low $131.52, high $304.73) — a potential gain of +200% on today's $64.17. Buyers look set to stay in control over this stretch.
In 2031, TWST is projected to trade between $127.86 and $313.27, averaging $192.32 — a potential gain of +200% from today's $64.17. That is up 0% on the projected 2030 average. Momentum favours further upside here.
Twist Bioscience Corporation's 2032 outlook centres on $202.20, within a $130.87 to $337.50 range. That is up +5% on the projected 2031 average. That marks a +215% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, TWST could reach as high as $488.25, with a base case around $286.13 and support toward $180.54 — roughly +346% from $64.17. Momentum favours further upside here.
Expect TWST to range from $211.40 to $597.82 through 2034. The $343.34 average target implies a +435% move from current prices. That is up +20% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The TWST price prediction for 2035 points to an average of $387.05 (low $232.75, high $686.64) — a potential gain of +503% on today's $64.17. Momentum favours further upside here.
In 2040, TWST is projected to trade between $321.92 and $1,145.95, averaging $597.66 — a potential gain of +831% from today's $64.17. That is up +54% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Twist Bioscience Corporation's 2050 outlook centres on $1,285.03, within a $578.26 to $2,753.99 range. That is up +115% on the projected 2040 average. That marks a +19.0x change versus current levels. Momentum favours further upside here.
Investing $1,000 in TWST today (≈ 15.583606 TWST) could be worth
$20,025.35
+$19,025.35 (+1903%) by 2050 · US Dollar
Based on the average projected TWST price of $1,285.03 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TWSTwould be worth at today's price.
$1,000 invested in TWST on May 27, 2025 (≈ 34.00204 TWST) would be worth
$2,181.91
+$1,181.91 (+118.2%) today · 2.18× · US Dollar
Based on a TWST entry price of $29.41 vs. today's $64.17.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $53.66 | $1,195.86 | +19.6% |
| 1 month ago | $61 | $1,051.97 | +5.2% |
| 3 months ago | $48.71 | $1,317.39 | +31.7% |
| 6 months ago | $32.01 | $2,004.69 | +100.5% |
| 1 year ago | $29.41 | $2,181.91 | +118.2% |
| All time (5.0y) ago | $105.88 | $606.06 | -39.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TWST forecast.
Our base-case forecast reaches $130.00 around 2028.
Implied market cap at $130.00: $8.1B
The multi-year forecast shows substantial upside across the 2026–2050 horizon. The 2026 forecast lists an average of $64.87, rising to $109.70 in 2027, $142.39 in 2028, $160.43 in 2029, and $194.29 in 2030, with continued gains thereafter (2031 $193.09; 2032 $203.20; 2033 $290.12; 2034 $347.27; 2035 $390.47).
Beyond 2035, the forecast envisions further upside, with a 2040 average of $602.40 and a 2050 average of $1,286.00. Return on investment forecasts rise accordingly, showing 69.1% in 2027, 119.5% in 2028, 147.3% in 2029, 199.5% in 2030, 197.7% in 2031, 213.3% in 2032, 347.2% in 2033, 435.3% in 2034, 501.9% in 2035, 828.6% in 2040, and 1882.4% in 2050. These figures reflect a bullish trajectory but are estimates, not guarantees, and depend on market conditions and other uncertain factors.
Overall, the outlook remains bullish across the long horizon, with pronounced upside by 2040 and 2050. Investors should weigh the strong upside potential against the inherent uncertainties of long-horizon forecasts.
Tap a question to reveal the answer.
Avg price $194.29; min $131.83; max $310.42; ROI 199.5%; sentiment BULLISH.
Forecasts show bullish sentiment with rising averages and high upside by 2050 (avg $1,286.00; ROI 1882.4%). The path includes strong upside projections through 2030 and beyond, but these are estimates, not guarantees.
Yes. The 2027 forecast lists an avg of $109.70 and a max of $155.56, while the 2026 max is $100.40.
Avg $64.87; min $32.39; max $100.40; ROI 0%; sentiment NEUTRAL.
Current price $64.87; market cap $4.04B; rank 1522.
Twist Bioscience Corporation Community Discussion
0Share your Twist Bioscience Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.